MedPath

Advanced liver imaging in Gaucher Disease: a pilot study

Conditions
Gaucher Disease
lysosomal storage disorder
10014699
10019654
Registration Number
NL-OMON34763
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
21
Inclusion Criteria

Patients with Gaucher Disease;
Over 18 years of age;
BMI under 27 kg/m2;
At least 2 years of therapy;
Written informed consent

Exclusion Criteria

Known history of chronic liver disease other than caused by Gaucher Disease;
Alcohol more than 3 units per day for males and more than 2 units per day for females;
Contra-indications for MRI scanning (standard checklist);
younger than 18 years of age;
use of medications that are known to affect the liver (see protocol)

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The differences between Gaucher Disease patients with high risk versus normal<br /><br>risk and Gaucher Disease patients versus healthy volunteers in:<br /><br>-Elasticity measurements of the liver obtained with MR Elastography and<br /><br>FibroScan<br /><br>-Iron accumulation in the liver assessed by MRI and biochemical values.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>The differences between Gaucher Disease patients with high risk versus normal<br /><br>risk and Gaucher Disease patients versus healthy volunteers in: The spectrum of<br /><br>glucosylceramide in the liver obtained with 1H-MR Spectroscopy.</p><br>
© Copyright 2025. All Rights Reserved by MedPath